RxDoctor Payments DataLook up a doctor →

Gnanagurdasan Prakasam

Pediatric Endocrinology · Sacramento, CANPI 1871586065

Payments from drug & device makers

$3,784,257in general payments, 2019–2025

Across 3,236 payments — averaging $1169.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$977K
  • Eli Lilly$570K
  • Medtronic$408K
  • Pfizer$331K
  • Novo Nordisk$326K
  • Mannkind Corporation$285K
  • plus $888K from 40 others
$28,175in research payments, 2019–2025

Across 13 payments — averaging $2167.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$23K
  • Pfizer$4K
  • Mannkind Corporation$695

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Dexcom, Inc.85$976,711
Eli Lilly28$570,120
Medtronic(2 entities)74$408,043
Pfizer39$330,578
Novo Nordisk390$325,764
Mannkind Corporation443$285,228
Ultragenyx Pharmaceutical Inc.251$164,185
Novo Nordisk AS973$156,557
AbbVie(2 entities)249$107,656
AstraZeneca159$91,937
Ascendis Pharma Endocrinology Inc39$67,018
Neurocrine Biosciences, Inc.75$56,266
Biomarin Pharmaceutical Inc.21$54,001
Merck27$45,485
Kyowa Kirin, Inc.88$44,030
Lilly USA, LLC79$41,196
Abbott45$16,367
Janssen Research & Development, LLC4$12,256
Dompe Farmaceutici S.p.a.1$10,300
Sanofi-aventis U.S. LLC22$10,095
Ferring Pharmaceuticals Inc.19$5,101
Roche Diabetes Care, Inc.1$2,900
Tandem Diabetes Care, Inc.19$481
Companion Medical, Inc.16$316
Tolmar Pharmaceuticals, Inc.19$280
Zealand Pharma US, Inc.11$200
Azurity Pharmaceuticals, Inc.8$176
Vistapharm, Inc.8$150
Tolmar, Inc.5$132
BD5$126
Xeris Pharmaceuticals, Inc.6$92
Soleno Therapeutics, Inc.3$73
Insulet Corporation4$68
Lifescan, Inc.4$65
Ipsen Biopharmaceuticals, Inc2$48
Amgen(2 entities)2$38
Amphastar Pharmaceuticals, Inc.2$38
Krystal Biotech Inc1$31
IBSA Pharma Inc.2$28
Embecta Corp.1$21
Endo USA, Inc.1$20
Ascensia Diabetes Care US Inc.1$19
Nevro Corp.1$17
Arbor Pharmaceuticals, Inc.1$15
Endo Pharmaceuticals Inc.1$14
Regeneron Healthcare Solutions, Inc.1$13

How this compares

$3,784,257 in reported general payments places this provider in the 95th percentile of 168 pediatric endocrinology providers in California.

See all pediatric endocrinology providers in California →

Other pediatric endocrinology in Sacramento

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →